Quince Therapeutics Files Q1 2025 10-Q
Ticker: QNCX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1662774
| Field | Detail |
|---|---|
| Company | Quince Therapeutics, Inc. (QNCX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
Related Tickers: QNXC
TL;DR
Quince Therapeutics (QNXC) filed its Q1 2025 10-Q. Check financials.
AI Summary
Quince Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Cortexyme, Inc., is involved in the biological products sector. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Quince Therapeutics, crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Quince Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025)
- 1231 — Fiscal Year End (Indicates the company's fiscal year closes on December 31st)
Key Players & Entities
- Quince Therapeutics, Inc. (company) — Filer of the 10-Q report
- Cortexyme, Inc. (company) — Former name of Quince Therapeutics, Inc.
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date of the report
FAQ
What is the primary business of Quince Therapeutics, Inc.?
Quince Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its SIC code [2836].
When was Quince Therapeutics, Inc. formerly known as?
Quince Therapeutics, Inc. was formerly known as Cortexyme, Inc., with a name change date of January 4, 2016.
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is March 31, 2025 (20250331).
What is the filing date of this 10-Q?
The filing date (As Of Date) for this 10-Q is May 13, 2025 (20250513).
Where is Quince Therapeutics, Inc. located?
Quince Therapeutics, Inc. is located at 611 Gateway Blvd., Suite 273, South San Francisco, CA 94080.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Quince Therapeutics, Inc. (QNCX).